Johnson & Johnson (JNJ) Shares Outstanding (2009 - 2026)

Johnson & Johnson has disclosed Shares Outstanding across 18 years of filings, most recently posting $3.1 billion for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $3.1 billion, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 billion (changed 0.0% YoY), and the FY2025 annual result was $3.1 billion, changed 0.0% from the prior year.
• Shares Outstanding came in at $3.1 billion for Q1 2026 at Johnson & Johnson, roughly flat from $3.1 billion in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $3.1 billion in Q1 2022 to a low of $3.1 billion in Q1 2022.
• The 5-year median for Shares Outstanding is $3.1 billion (2022), against an average of $3.1 billion.
• Peak annual rise in Shares Outstanding reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
• Johnson & Johnson's Shares Outstanding stood at $3.1 billion in 2022, then changed by 0.0% to $3.1 billion in 2023, then changed by 0.0% to $3.1 billion in 2024, then changed by 0.0% to $3.1 billion in 2025, then changed by 0.0% to $3.1 billion in 2026.
• The last three Shares Outstanding figures came in at $3.1 billion (Q1 2026), $3.1 billion (Q4 2025), and $3.1 billion (Q3 2025), per Business Quant data.